In line with these results, TAp63α -as well as IKKβ and Xbp1s- was increased in the liver from obese NAFLD/NASH patients, suggesting that the role of p63 in hepatic lipid metabolism may be important in human liver diseases. This evidence concerns the gene IKBKB and metabolic dysfunction-associated steatotic liver disease.